FDA authorizes use of new device to treat esophageal birth defect in babies - FDA Press Releases

The U.S. Food and Drug Administration today authorized use of the Flourish Pediatric Esophageal Atresia Anastomosis, a first-of-its-kind medical device to treat infants up to one year old for a birth defect that causes a gap in their esophagus, called esophageal atresia.

from Food and Drug Administration--Press Releases http://ift.tt/2r8VNvW
via IFTTT